Literature DB >> 17341201

Formulation and physiological factors influencing CNS delivery upon intranasal administration.

Tushar K Vyas1, Sandip B Tiwari, Mansoor M Amiji.   

Abstract

The treatment of central nervous system (CNS) disorders is particularly challenging because of a variety of formidable barriers to effective and persistent delivery of therapeutic compounds. This review discusses the potential of intranasal drug administration as a means to bypass a major barrier, the blood-brain barrier, and allow for direct delivery of drugs into the CNS. The article emphasizes physicochemical properties of intranasal drug formulations as well as relevant anatomical and physiological factors in intranasal delivery of drugs for CNS therapy. Published examples of intranasal administration of small molecular weight drugs, peptides and proteins, and novel formulations for delivering a broad spectrum of molecules are discussed. Finally, the article provides several strategies for effectively enhancing nose-to-brain transport of drug molecules through rational formulation design and optimization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17341201     DOI: 10.1615/critrevtherdrugcarriersyst.v23.i4.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  3 in total

1.  Noninvasive routes of proteins and peptides drug delivery.

Authors:  P K Sharma; Sumedha Bansal; Arunabha Banik
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

2.  Direct nose to brain delivery of small molecules: critical analysis of data from a standardized in vivo screening model in rats.

Authors:  Deborah Dhuyvetter; Fetene Tekle; Maxim Nazarov; Rob J Vreeken; Herman Borghys; Frederik Rombouts; Ilse Lenaerts; Astrid Bottelbergs
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 3.  Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System.

Authors:  Tyler P Crowe; Walter H Hsu
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.